Related Experiment Video
Updated: Aug 19, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase
Anis Feki1, Charles Edward Jefford, Philip Berardi
1Biology of Aging Laboratory, Department of Geriatrics, University of Geneva, Chemin de Petit Bel Air 2, CH-1225 Geneva/Chêne-Bourg, Switzerland.
Abstract:
The BRCA1-associated RING domain protein BARD1 acts with BRCA1 in double-strand break repair and ubiquitination. BARD1 plays a role as mediator of apoptosis by binding to and stabilizing p53, and BARD1-repressed cells are resistant to apoptosis. We therefore investigated the mechanism by which BARD1 induces p53 stability and apoptosis. The apoptotic activity of p53 is regulated by phosphorylation. We demonstrate that BARD1 binds to unphosphorylated and serine-15 phosphorylated forms of p53 in several cell types and that the region required for binding comprises the region sufficient for apoptosis induction. In addition, BARD1 binds to Ku-70, the regulatory subunit of DNA-PK, suggesting that the mechanism of p53-induced apoptosis requires BARD1 for the phosphorylation of p53. Upregulation of BARD1 alone is sufficient for stabilization of p53 and phosphorylation on serine-15, as shown in nonmalignant epithelial cells and ovarian cancer cells, NuTu-19, which are defective in apoptosis induction and express aberrant splice variants of BARD1. Stabilization and phosphorylation of p53 in NuTu-19 cells, as well as apoptosis, can be induced by the exogenous expression of wild-type BARD1, suggesting that BARD1, by binding to the kinase and its substrate, catalyses p53 phosphorylation.
Insights
BRCA1-associated RING domain protein BARD1 stabilizes p53, inducing apoptosis. BARD1 facilitates p53 phosphorylation by binding to the kinase and substrate, crucial for cell death.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- BRCA1-associated RING domain protein BARD1 (BARD1) is crucial for DNA repair and ubiquitination.
- BARD1 mediates apoptosis by stabilizing p53, a key tumor suppressor.
- Dysfunctional BARD1 leads to apoptosis resistance.
Purpose of the Study:
- To elucidate the mechanism by which BARD1 induces p53 stability and apoptosis.
- To investigate the role of BARD1 in p53 phosphorylation and subsequent apoptosis induction.
Main Methods:
- Co-immunoprecipitation assays to detect protein-protein interactions.
- Analysis of p53 phosphorylation at serine-15.
- Exogenous expression of wild-type BARD1 in cancer cells with BARD1 defects.
Main Results:
- BARD1 binds to both unphosphorylated and serine-15 phosphorylated p53.
- BARD1 interacts with Ku-70, suggesting a role in DNA-PK mediated p53 phosphorylation.
- Upregulation of BARD1 alone stabilizes p53 and induces serine-15 phosphorylation.
- Restoration of wild-type BARD1 in defective cells re-establishes p53 stabilization, phosphorylation, and apoptosis.
Conclusions:
- BARD1 acts as a catalyst for p53 phosphorylation, essential for apoptosis induction.
- BARD1's interaction with both p53 and DNA-PK components facilitates this process.
- Defects in BARD1 can impair apoptosis, highlighting its therapeutic potential in cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

